No shortage on file

ENALAPRILAT INJECTION USP

HIKMA CANADA LIMITED

Quick answers

Is there a shortage of ENALAPRILAT INJECTION USP in Canada?

No. There is no current shortage of ENALAPRILAT INJECTION USP 1.25MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on fileNone found

Checked by MedShort2026-11-12

DIN

02388499

Strength

1.25MG

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

ENALAPRILAT

See all ENALAPRILAT products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

2026-09-25

Resolved

Disruption of the manufacture of the drug.

Other Products from HIKMA CANADA LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION USP

9MG · DIN 02304341

ACETYLCYSTEINE SOLUTION USP

200MG · DIN 02459906

ATROPINE INJECTION BP

0.4MG · DIN 02432188

ATROPINE INJECTION BP

0.6MG · DIN 02432196

AZACITIDINE FOR INJECTION

100MG · DIN 02507668

BACLOFEN INJECTION

0.05MG · DIN 02457059

BACLOFEN INJECTION

2MG · DIN 02457075

BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION

0.2% · DIN 02515377

CEFAZOLIN FOR INJECTION

500MG · DIN 02437104

CEFAZOLIN FOR INJECTION

10G · DIN 02437120

CEFAZOLIN FOR INJECTION

1G · DIN 02437112

CEFEPIME FOR INJECTION USP

2G · DIN 02499096